$113.86
0.67% day before yesterday
NYSE, Sep 06, 10:10 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$113.86
+4.36 3.98% 1M
-5.48 4.59% 6M
+3.79 3.44% YTD
+12.30 12.11% 1Y
-15.08 11.70% 3Y
+27.82 32.33% 5Y
+71.05 165.97% 10Y
NYSE, Closing price Fri, Sep 06 2024
+0.76 0.67%
ISIN
US0028241000
Symbol
ABT
Sector

Key metrics

Market capitalization $198.11b
Enterprise Value $205.88b
P/E (TTM) P/E ratio 35.94
EV/FCF (TTM) EV/FCF 36.41
EV/Sales (TTM) EV/Sales 5.06
P/S ratio (TTM) P/S ratio 4.86
P/B ratio (TTM) P/B ratio 5.04
Dividend yield 1.83%
Last dividend (FY23) $2.08
Revenue growth (TTM) Revenue growth 1.24%
Revenue (TTM) Revenue $40.73b
EBIT (operating result TTM) EBIT $6.61b
Free Cash Flow (TTM) Free Cash Flow $5.65b
Cash position $7.22b
EPS (TTM) EPS $3.17
P/E forward 33.69
P/S forward 4.75
EV/Sales forward 4.93
Short interest 0.73%
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Abbott Laboratories forecast:

19x Buy
70%
8x Hold
30%

Analyst Opinions

27 Analysts have issued a Abbott Laboratories forecast:

Buy
70%
Hold
30%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
40,725 40,725
1% 1%
100%
- Direct Costs 20,106 20,106
1% 1%
49%
20,619 20,619
3% 3%
51%
- Selling and Administrative Expenses 8,028 8,028
3% 3%
20%
- Research and Development Expense 2,731 2,731
4% 4%
7%
9,860 9,860
6% 6%
24%
- Depreciation and Amortization 3,247 3,247
1% 1%
8%
EBIT (Operating Income) EBIT 6,613 6,613
9% 9%
16%
Net Profit 5,536 5,536
8% 8%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Positive
Reuters
2 days ago
Abbott has launched its over-the-counter continuous glucose monitoring system Lingo in the United States, the company said on Thursday.
Neutral
Investors Business Daily
2 days ago
Abbott Laboratories launches its newest CGM in the U.S. on Thursday. The biosensor named Lingo is the first-ever for people without diabetes.
Positive
CNBC
2 days ago
Abbott Laboratories on Thursday announced its over-the-counter continuous glucose monitor Lingo is available in the U.S. Lingo can be purchased without a prescription, and it's intended for adults who do not take insulin that want to improve their overall health and wellness.
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Employees 114,000
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today